A chemical commonly used to give vape products a vanilla flavour altered the behaviour of human embryonic stem cells in laboratory experiments, raising questions about how some vaping ingredients could affect the earliest stages of development.
Researchers at the University of California, Riverside found that vanillin interfered with the cells' ability to remain flexible enough to develop into different types of tissue. Instead, exposed cells showed a shift toward forming one particular type of embryonic tissue.
The finding is intriguing because the changes occurred at concentrations that did not simply kill the cells. Instead, vanillin appeared to alter the developmental programme the cells were following.
But the study has a crucial limitation: the experiments were conducted on cells in a laboratory, not on pregnant women or developing embryos inside the body. The results therefore cannot show that vaping vanillin causes miscarriage, birth defects or other pregnancy complications.
Researchers Watched Cells Make an Early Developmental Choice
The cells used in the study were human embryonic stem cells, which can develop into many different cell types.
This flexibility is known as pluripotency. During early development, cells gradually become more specialized, eventually giving rise to the tissues that make up the body.
That means the period when cells are deciding what they will become is particularly sensitive to changes in their environment.
The researchers wanted to see whether chemicals used in vaping products could interfere with that process. Vanillin was one of the substances they tested because it is a common flavoring compound and can be present in e-cigarette liquids.
What they saw was not simply widespread cell damage.
Instead, the cells began changing direction.
Vanillin Shifted the Cells Toward One Tissue Type
After exposure to vanillin, the stem cells became less capable of maintaining their pluripotent state.
They also showed a greater tendency to develop into endoderm, one of the three major groups of cells formed during early embryonic development.
The other two groups, ectoderm and mesoderm, eventually contribute to many structures throughout the body. The nervous system, for example, develops largely from ectoderm, while mesoderm contributes to tissues including muscle and bone.
The researchers found that vanillin exposure reduced the cells' ability to move normally toward those developmental pathways.
At higher concentrations, the effects became more severe. The cells showed poorer growth and increased cell death.
But the lower-concentration findings were particularly interesting because they suggested that a chemical does not necessarily have to kill a cell to interfere with its development. It may instead alter the signals that tell the cell what to become.
That led researchers to a more specific question: how was vanillin changing those signals?
A Cell-Surface Channel Appeared to Be Involved
The team traced the effect to a protein called TRPV4, which sits on the surface of cells and acts as a channel that allows calcium to enter.
Calcium is more than a mineral needed for healthy bones. Inside cells, it also acts as a messenger, helping control processes such as movement, growth, and changes in gene activity.
In the experiments, vanillin activated TRPV4 and triggered an increase in calcium entering the cells.
The researchers then blocked the channel.
When TRPV4 was inhibited, many of the developmental changes caused by vanillin were reduced. That suggested the protein was an important part of the pathway linking the flavoring chemical to the changes seen in the stem cells.
The result gives scientists a possible biological explanation for the cellular effects, rather than simply showing that something changed after exposure.
The Experiment Does Not Show What Happens During Pregnancy
Despite the connection to embryonic cells, the findings should not be interpreted as evidence that vanilla-flavored vaping causes birth defects.
The researchers did not study pregnancies, fetuses or embryos developing inside a human body. They worked with cultured cells under controlled laboratory conditions.
That distinction matters because exposure inside the body is much more complicated. A chemical inhaled from a vape must enter the respiratory system, reach the bloodstream and potentially reach reproductive tissues before it could affect a developing pregnancy.
The amount that reaches an embryo could also differ substantially from the concentrations used in a laboratory dish.
For those reasons, the researchers said their experiments cannot establish whether vanillin causes embryo death or malformations in humans. More research would be needed to determine whether the cellular effects occur at relevant exposure levels in the body.
Why Flavoring Chemicals Deserve a Closer Look
The study nevertheless raises a broader question about what happens to the individual chemicals added to vaping products.
Flavorings are designed to change the taste or sensation of an e-cigarette, but they are still chemicals that enter the body when the product is used.
Vanillin is only one example.
The researchers are also investigating other compounds found in vaping products, including WS-23, a synthetic cooling agent used to create a cooling sensation without the flavor of menthol. Their work is part of a broader effort to understand how individual vape ingredients can affect cells involved in early development.
That research could eventually help determine whether certain ingredients deserve greater scrutiny, particularly during periods when developing cells are undergoing rapid changes.
For now, the vanillin findings remain a laboratory signal rather than proof of harm during pregnancy.
What makes the result worth watching is the specific change researchers observed: the cells did not simply stop growing. A chemical used to create a familiar flavor appeared to interfere with the instructions guiding cells toward their earliest developmental paths.
Whether that effect matters inside the human body is the question future studies will have to answer.
